"In accordance with ASX Listing Rule 17.1, the Company requests an immediate trading halt in respect of its securities (ASX Code: ANP), pending the release of an announcement regarding US Food and Drug Administration response to the Company’s rare paediatric disease designation request for ATL1102 in DMD."
Positive outcome??
.
Ann: Trading Halt, page-2
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.5¢ |
Change
0.002(2.74%) |
Mkt cap ! $65.81M | |||
| Open | High | Low | Value | Volume |
| 7.3¢ | 7.5¢ | 7.3¢ | $12.12K | 163.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 100000 | 7.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.5¢ | 100 | 1 |
View Market Depth
| Last trade - 11.46am 02/05/2024 (20 minute delay) ? |
|
|||||
|
Last
7.5¢ |
Change
0.002 ( 4.17 %) |
||||
| Open | High | Low | Volume | ||
| 7.5¢ | 7.5¢ | 7.5¢ | 7600 | ||
| Last updated 11.45am 02/05/2024 ? | |||||
| PER (ASX) Chart |